Global Neurodegenerative Diseases Market 2015-2019

1. Top 10 Diabetes Care Technologies, Devices and Therapeutics Markets - Growth, Global Share, Industry Overview, Analysis, Trends Opportunities and Forecast 2012 - 2020 Global Neurodegenerative Diseases Market 2015-2019 Growth, Global Share, Industry Overview, Analysis, Trends Opportunities and Forecast

2. Description Report Overview About neurodegenerative diseases According to the EU JPND, neurodegenerative diseases refer to conditions that involve the neurons in the brain. These conditions can affect balance, movement, speech, and respiratory and cardiac functions. They can be inherited or be of unknown etiology. Neurodegenerative diseases are incurable and are severely debilitating. They result in progressive degeneration of nerve cells, causing them to die eventually. These diseases cause ataxia and dementia in people, which can have a serious impact on the mental health of patients. Some examples of neurodegenerative diseases are Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, multiple sclerosis, amyotrophic lateral sclerosis, and epilepsy. Huntington’s disease and amyotrophic lateral sclerosis are rare diseases, unlike Alzheimer’s disease and Parkinson’s disease which have a high degree of prevalence. The global neurodegenerative diseases market to grow at a CAGR of 4.77 percent over the period 2014-2019. Read more details at: http://www.bigmarketresearch.com/global-neurodegenerative-diseases-2015-2019-market

3. Key Benefits Summery Covered in this report This report covers the present scenario and the growth prospects of the global neurodegenerative diseases market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of neurodegenerative diseases. The market includes data from the sales of various drugs used in the treatment of: • Alzheimer's Disease • Parkinson's Disease • Multiple Sclerosis • Epilepsy • Huntington's Disease The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the global neurodegenerative diseases market. The vendor landscape section includes a market share analysis of the major vendors along with the performances of their product portfolios. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by vendors and the market at large, as well as the key trends that are emerging in the market.

4. Key Audiences Key Regions • Americas • APAC • EMEA Key vendors • Biogen Idec • Merck Serono • Novartis • Pfizer • Teva Pharmaceutical Industries • UCB

5. Table Of Contents Key Audiences Other Prominent Vendors • AB Science • Abbvie • Acorda Therapeutics • Actavis • Active Biotech • Adamas Pharmaceuticals • Akorn • Archer Pharmaceuticals • Astellas • Auspex Pharmaceuticals • Bayer • BoehringerIngelheim • Covis • DesitinArzneimittel • Eisai

6. Table Of Contents Market Trends: Market driver • High unmet medical needs • For a full, detailed list, view our report Market Challenge • Generic erosion • For a full, detailed list, view our report Market trend • Reformulation of marketed drugs • For a full, detailed list, view our report

7. Table Of Contents Market Trends: Key Questions Answered in this Report • What will the market size be in 2019 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors? Enquire about report:http://www.bigmarketresearch.com/report-enquiry/222191

8. Get Full Information At: http://www.bigmarketresearch.com/global-neurodegenerative-diseases-2015-2019-market